TT
Thomas Trimarchi (President and CFO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $1.1M of BBIO (16,934 sh across 2 lots, as filed), executed Nov 17 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.9M
shares × price, as filed
Last traded
May 18
Filed May 19
Median ADV $293.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
BBIORecent filings
BBIOSALE
BridgeBio Pharma, Inc.
View filing →
$888K13,651 sh across 2 lots
Exec May 18
Filed May 19 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $1.0M
13,400 sh × $74.71
Exec Feb 17
Filed Feb 18 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $1.1M
16,934 sh across 2 lots
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $2.1M
42,237 sh × $49.48
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $872K
17,353 sh across 2 lots
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET